Venture capitalists have invested $123 million in Michigan companies so far in 2010, according to a report released today by the Ann Arbor-based Michigan Venture Capital Association.

That's up 35 percent compared to the same period in 2009, MVCA reported. Some $51.75 million was delivered to one company, Cerenis Therapeutics, a biotech firm with dual headquarters in Ann Arbor and France.

"This report conveys the progress the venture and entrepreneurial community has made in Michigan," MVCA executive director LeAnn Auer said in a statement. "Our year-to-date numbers are substantially higher than last year, proving there are both exceptional companies to fund in our state as well as a growing VC community here to support them."

VC investors have made 10 investments in Michigan companies in 2010. Those investments include $7 million for Ann Arbor-based battery startup Sakti3, $6 million for Scio Township-based medical devices maker Accuri Cytometers, $5 million for Ann Arbor-based medical devices startup CytoPherx.

Other startups that have pulled in VC dollars in 2010 include Lycera ($11 million) and Delphinus Medical Technologies ($8 million), firms that have moved into the Plymouth Township business incubator called the Michigan Life Science and Innovation Center, which is managed by Ann Arbor SPARK.

Contact AnnArbor.com's Nathan Bomey at (734) 623-2587 or nathanbomey@annarbor.com. You can also follow him on Twitter or subscribe to AnnArbor.com's newsletters.